Therapeutic implications

P. J. Barnes (London, United Kingdom)

Source: Annual Congress 2011 - Accelerated lung ageing in COPD
Session: Accelerated lung ageing in COPD
Session type: Symposium
Number: 1397
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). Therapeutic implications. Annual Congress 2011 - Accelerated lung ageing in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Therapeutic and management implications
Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited
Year: 2010


Therapeutic implications
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009


Therapeutic implications
Source: Annual Congress 2011 - Why are small airways important in asthma? An ERS/World Allergy Organization joint symposium
Year: 2011


Clinical implications
Source: Annual Congress 2007 - Pulmonary biomarkers in COPD
Year: 2007


Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018


Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008


Therapeutic management - Current status and future developments
Source: COVID-19 Videos
Year: 2020

Clinical implications – potential future developments in EBC research
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007


Oxygen at home: benefits, practical implications and pitfalls
Source: Annual Congress 2012 - Primary Care Programme
Year: 2012


Individualised staging: practical implications
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Perspectives for the future
Source: Eur Respir Monogr 2016; 71: 260-274
Year: 2016


Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008



Indications and Rationale
Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation
Year: 2012


Targeting mucus as a new therapeutic avenue?
Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner?
Year: 2011


Physiologic rationale and clinical pitfalls
Source: Virtual Congress 2021 – High flow nasal cannula in adults with acute respiratory failure
Year: 2021